Instructions to Authors – Abstract

Please follow the instructions given online, otherwise your abstract cannot be selected for review. A summary of the guidelines is as follows:

• The abstract language is English
• The templates provided are the only format accepted please see “How to write and submit an EACTS Abstract” below.
• There should be no more than 8 authors
• Since the abstracts will be judged anonymously, the text may not reveal the institutional affiliation
• Mark the category which best describes the subject of your abstract. If the paper is to be considered for any award or prize, mark the corresponding field when submitting the abstracts. (See Awards and Prize details – please note that to complete your abstract submission, you will be required to upload the applicable covering letter from your Director of Service or Laboratory in the Institution at which the research programme has been undertaken)
• Each abstract submitted to the Association for possible presentation at the EACTS Annual Meeting must summarize an original contribution and must not have been submitted, presented, published or accepted for presentation or publication elsewhere.
• Please note that it is not possible to make any corrections to the abstract content or information (such as Presenter details, authors list etc). In order to correct your abstract you must withdraw it and submit a new corrected version prior to the deadline. Note that, such replacement of the abstract is not possible after the deadline.  In the case of errors in your abstract discovered after the deadline, you may indicate the correction during the presentation at the congress. However, changes will not be included in the publications.  If accepted, your abstract will be published as submitted.

Abstracts will not be accepted unless they are submitted according to the format and instructions described previously, and submitted using the online system no later than the dates given above.

How to write and submit an EACTS Abstract

Fig. 1	.                     .	Fig. 2

• Each abstract submitted to the Association for possible presentation at the EACTS Annual Meeting must summarize an original contribution and must not have been submitted, presented, published or accepted for presentation or publication elsewhere. *
• For all Abstracts which are accepted for presentation at the EACTS Annual Meeting, the full manuscript MUST then be submitted to the European Journal of Cardio-Thoracic Surgery or Interactive CardioVascular and Thoracic Surgery, by 19 September 2023.  * (http://www.editorialmanager.com/ejcts/default.aspx)
• Each abstract accepted for presentation a the EACTS Annual Meeting must be presented by the nominated author in-person in Milan. The nominated presenter must be registered to attend the meeting by 1 July 2023 or the abstract could be removed from the programme.  *
• Selected Congress sessions will be webcasted. EACTS will use the entire presentation for webcasting purposes.
• Ensure that you have permission from all co-authors to submit the abstract on their behalf and to grant EACTS the exclusive license to publish the abstract and the full article if accepted.
• You must consider the content of your presentation carefully to avoid bringing EACTS into disrepute. You must be aware that EACTS has a zero-tolerance approach to sexism and other forms of discrimination.
• Your study/research methodology must have been approved by local ethical committees or conform to standards currently applied in the country of origin.

*Please note that failure to meet these conditions can result in ALL authors being restricted from submitting an abstract or manuscript for 2 years.

Copyright

The audio-visual recording of the scientific presentations will be the property of the EACTS.  Authors will be notified in writing by July 2023 if the EACTS Programme Committee has accepted their abstract(s).

During abstract submission any disclosures should be made in the relevant section of the abstract submission system and not included on the abstract itself.

For abstracts that are accepted for presentation and the subsequent manuscript submission, the Editor requires authors to disclose any commercial associations that might pose a conflict of interest in connection with the submitted article.

All sources of funding for work should be acknowledged in a footnote on the title page, as should all institutional affiliations of the authors (including corporate appointments). Other kinds of associations, such as consultancies, stock ownership or other equity interests or patent licensing arrangements should be disclosed to the Editor in the covering letter at the time of submission. If no conflict of interest exists, please state this in the covering letter. The Editor reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfill the above-mentioned requirements.

Presentation Guidelines

Abstracts / Late breaking clinical trials
Your allocated presentation time and discussion period will be indicated in your abstract acceptance email. Please note that only data projection will be available.